Triplet pregnancy complicated by a gradual decline in antithrombin-III activity and HELLP syndrome: a case report.

Abstract	We prospectively evaluated the antenatal changes in antithrombin-III (AT-III) activity and liver enzymes in a woman with a triplet pregnancy. A gradual decline in AT-III activity occurred in the absence of clinical signs of preeclampsia and preceded the onset of the typical HELLP syndrome in this patient. Monitoring of AT-III activity might help to avoid the development of severe HELLP syndrome.
Authors	A Izumi, H Minakami, S Matsubara, I Sato
Journal	The journal of obstetrics and gynaecology research (J Obstet Gynaecol Res) Vol. 24 Issue 4 Pg. 275-9 (Aug 1998) ISSN: 1341-8076 [Print] Australia
PMID	9798357 (Publication Type: Case Reports, Journal Article)
Chemical References	Haptoglobins Uric Acid Antithrombin III L-Lactate Dehydrogenase Alanine Transaminase
Topics	Adult Alanine Transaminase (blood) Antithrombin III (metabolism, pharmacology) Cesarean Section Female Fertilization in Vitro HELLP Syndrome (blood, enzymology, therapy) Haptoglobins (analysis) Humans L-Lactate Dehydrogenase (blood) Liver (enzymology) Male Platelet Count Pregnancy Pregnancy Complications (blood, enzymology) Pregnancy Outcome Pregnancy, Multiple (blood, metabolism, physiology) Prospective Studies Triplets Uric Acid (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!